Search

everythinglearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Composite biomaterials can precisely control immune responses for better disease treatment.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

IL-18 signaling helps mature Tregs move into the thymus.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Biodegradable scaffolds help regenerate wounds and hair by activating the immune system.

Alopecia areata involves unique activation of certain immune cells.

Controlling immune responses with biomaterials can reduce scarring and improve skin regeneration.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Special cells can help regrow hair in alopecia areata.

The skin's immune system helps it regenerate and fight infections.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Scientists can now create skin with hair by reprogramming cells in wounds.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Enhancing Tregs can protect against alopecia areata.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Immuno-cosmeceuticals from chicken egg yolk can effectively repair and improve damaged hair.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Nanotechnology can improve tissue healing by controlling immune responses.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.